Microglia-glioblastoma interactions: New role for Wnt signaling

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1868, Issue 1, 2017, Pages 333-340

  Matias, D ^a,b   Predes, D ^b   Niemeyer Filho, P ^a   Lopes, M C ^c   Abreu, J G ^b   Lima, F R S ^b   Moura Neto, V ^a  

^a Instituto Estadual do Cérebro Paulo Niemeyer   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Brain macrophages; Glioblastoma; Gliomas; Microglia; Wnt pathway

Indexed keywords

BETA CATENIN; WNT PROTEIN; CYTOKINE; SIGNAL PEPTIDE;

CANCER STEM CELL; CELL ACTIVATION; CELL INTERACTION; CELL SURVIVAL; GLIOBLASTOMA; HUMAN; MACROPHAGE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR GROWTH; WNT SIGNALING PATHWAY; ANIMAL; BRAIN TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; WNT SIGNALING;

ANIMALS; BRAIN NEOPLASMS; CYTOKINES; GLIOBLASTOMA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROGLIA; WNT SIGNALING PATHWAY;

EID: 85020654982     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2017.05.007     Document Type: Review

References (89)

1. Stupp, R., Hegi, M.E., Mason, W.P., van den Bent, M.J., Taphoorn, M.J., Janzer, R.C., Ludwin, S.K., Allgeier, A., Fisher, B., Belanger, K., Hau, P., Brandes, A.A., Gijtenbeek, J., Marosi, C., Vecht, C.J., Mokhtari, K., Wesseling, P., Villa, S., Eisenhauer, E., Gorlia, T., Weller, M., Lacombe, D., Cairncross, J.G., Mirimanoff, R.O., R. European Organisation for, T. Treatment of Cancer Brain, G. Radiation Oncology, G. National Cancer Institute of Canada Clinical Trials, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10 (2009), 459–466.
2. Louis, D.N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W.K., Ohgaki, H., Wiestler, O.D., Kleihues, P., Ellison, D.W., The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 131 (2016), 803–820.
3. Lima, F.R., Kahn, S.A., Soletti, R.C., Biasoli, D., Alves, T., da Fonseca, A.C., Garcia, C., Romao, L., Brito, J., Holanda-Afonso, R., Faria, J., Borges, H., Moura-Neto, V., Glioblastoma: therapeutic challenges, what lies ahead. Biochim. Biophys. Acta 1826 (2012), 338–349.
4. da Fonseca, A.C., Amaral, R., Garcia, C., Geraldo, L.H., Matias, D., Lima, F.R., Microglia in cancer: for good or for bad?. Adv. Exp. Med. Biol. 949 (2016), 245–261.
5. Garcia, C., Dubois, L.G., Xavier, A.L., Geraldo, L.H., da Fonseca, A.C., Correia, A.H., Meirelles, F., Ventura, G., Romao, L., Canedo, N.H., de Souza, J.M., de Menezes, J.R., Moura-Neto, V., Tovar-Moll, F., Lima, F.R., The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model. BMC Cancer, 14, 2014, 923.
6. da Fonseca, A.C., Matias, D., Garcia, C., Amaral, R., Geraldo, L.H., Freitas, C., Lima, F.R., The impact of microglial activation on blood-brain barrier in brain diseases. Front. Cell. Neurosci., 8, 2014, 362.
7. Eglitis, M.A., Mezey, E., Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 4080–4085.
8. Kierdorf, K., Erny, D., Goldmann, T., Sander, V., Schulz, C., Perdiguero, E.G., Wieghofer, P., Heinrich, A., Riemke, P., Holscher, C., Muller, D.N., Luckow, B., Brocker, T., Debowski, K., Fritz, G., Opdenakker, G., Diefenbach, A., Biber, K., Heikenwalder, M., Geissmann, F., Rosenbauer, F., Prinz, M., Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16 (2013), 273–280.
9. Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M.F., Conway, S.J., Ng, L.G., Stanley, E.R., Samokhvalov, I.M., Merad, M., Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330 (2010), 841–845.
10. Nimmerjahn, A., Kirchhoff, F., Helmchen, F., Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308 (2005), 1314–1318.
11. Hanisch, U.K., Kettenmann, H., Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10 (2007), 1387–1394.
12. Kettenmann, H., Hanisch, U.K., Noda, M., Verkhratsky, A., Physiology of microglia. Physiol. Rev. 91 (2011), 461–553.
13. Du, L., Zhang, Y., Chen, Y., Zhu, J., Yang, Y., Zhang, H.L., Role of microglia in neurological disorders and their potentials as a therapeutic target. Mol. Neurobiol., 2016.
14. da Fonseca, A.C., Badie, B., Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies. Clin. Dev. Immunol., 2013, 2013, 264124.
15. Olah, M., Raj, D., Brouwer, N., De Haas, A.H., Eggen, B.J., Den Dunnen, W.F., Biber, K.P., Boddeke, H.W., An optimized protocol for the acute isolation of human microglia from autopsy brain samples. Glia 60 (2012), 96–111.
16. Roggendorf, W., Strupp, S., Paulus, W., Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol. 92 (1996), 288–293.
17. Zhang, Z.M., Yang, Z., Zhang, Z., Distribution and characterization of tumor-associated macrophages/microglia in rat C6 glioma. Oncol. Lett. 10 (2015), 2442–2446.
18. Ye, X.Z., Xu, S.L., Xin, Y.H., Yu, S.C., Ping, Y.F., Chen, L., Xiao, H.L., Wang, B., Yi, L., Wang, Q.L., Jiang, X.F., Yang, L., Zhang, P., Qian, C., Cui, Y.H., Zhang, X., Bian, X.W., Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J. Immunol. 189 (2012), 444–453.
19. Dzaye, O.D. a, Hu, F., Derkow, K., Haage, V., Euskirchen, P., Harms, C., Lehnardt, S., Synowitz, M., Wolf, S.A., Kettenmann, H., Glioma stem cells but not bulk glioma cells upregulate IL-6 secretion in microglia/brain macrophages via toll-like receptor 4 signaling. J. Neuropathol. Exp. Neurol. 75 (2016), 429–440.
20. Pu, P., Zhang, Z., Kang, C., Jiang, R., Jia, Z., Wang, G., Jiang, H., Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther. 16 (2009), 351–361.
21. Liu, C., Tu, Y., Sun, X., Jiang, J., Jin, X., Bo, X., Li, Z., Bian, A., Wang, X., Liu, D., Wang, Z., Ding, L., Wnt/beta-catenin pathway in human glioma: expression pattern and clinical/prognostic correlations. Clin. Exp. Med. 11 (2011), 105–112.
22. Kikuchi, R., Nakamura, K., MacLauchlan, S., Ngo, D.T., Shimizu, I., Fuster, J.J., Katanasaka, Y., Yoshida, S., Qiu, Y., Yamaguchi, T.P., Matsushita, T., Murohara, T., Gokce, N., Bates, D.O., Hamburg, N.M., Walsh, K., An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease. Nat. Med. 20 (2014), 1464–1471.
23. Kamino, M., Kishida, M., Kibe, T., Ikoma, K., Iijima, M., Hirano, H., Tokudome, M., Chen, L., Koriyama, C., Yamada, K., Arita, K., Kishida, S., Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2. Cancer Sci. 102 (2011), 540–548.
24. Pukrop, T., Dehghani, F., Chuang, H.N., Lohaus, R., Bayanga, K., Heermann, S., Regen, T., Van Rossum, D., Klemm, F., Schulz, M., Siam, L., Hoffmann, A., Trumper, L., Stadelmann, C., Bechmann, I., Hanisch, U.K., Binder, C., Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia 58 (2010), 1477–1489.
25. Halleskog, C., Mulder, J., Dahlstrom, J., Mackie, K., Hortobagyi, T., Tanila, H., Kumar Puli, L., Farber, K., Harkany, T., Schulte, G., WNT signaling in activated microglia is proinflammatory. Glia 59 (2011), 119–131.
26. Halleskog, C., Schulte, G., WNT-3A and WNT-5A counteract lipopolysaccharide-induced pro-inflammatory changes in mouse primary microglia. J. Neurochem. 125 (2013), 803–808.
27. L'Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Morale, M.C., Serapide, M.F., Pluchino, S., Marchetti, B., Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease. J. Mol. Cell Biol. 6 (2014), 13–26.
28. Kettenmann, H., Neuroscience: the brain's garbage men. Nature 446 (2007), 987–989.
29. Lisi, L., Stigliano, E., Lauriola, L., Navarra, P., Dello Russo, C., Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells. ASN Neuro 6 (2014), 171–183.
30. Ginhoux, F., Prinz, M., Origin of microglia: current concepts and past controversies. Cold Spring Harb. Perspect. Biol., 7, 2015, a020537.
31. Hambardzumyan, D., Gutmann, D.H., Kettenmann, H., The role of microglia and macrophages in glioma maintenance and progression. Nat. Neurosci. 19 (2016), 20–27.
32. de Charette, M., Marabelle, A., Houot, R., Turning tumour cells into antigen presenting cells: the next step to improve cancer immunotherapy?. Eur. J. Cancer 68 (2016), 134–147.
33. Zhang, X., Rao, A., Sette, P., Deibert, C., Pomerantz, A., Kim, W.J., Kohanbash, G., Chang, Y., Park, Y., Engh, J., Choi, J., Chan, T., Okada, H., Lotze, M., Grandi, P., Amankulor, N., IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression. Neuro-Oncology 18 (2016), 1402–1412.
34. Tanaka, T., Murakami, K., Bando, Y., Yoshida, S., Interferon regulatory factor 7 participates in the M1-like microglial polarization switch. Glia 63 (2015), 595–610.
35. Coniglio, S.J., Eugenin, E., Dobrenis, K., Stanley, E.R., West, B.L., Symons, M.H., Segall, J.E., Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling. Mol. Med. 18 (2012), 519–527.
36. Markovic, D.S., Vinnakota, K., Chirasani, S., Synowitz, M., Raguet, H., Stock, K., Sliwa, M., Lehmann, S., Kalin, R., van Rooijen, N., Holmbeck, K., Heppner, F.L., Kiwit, J., Matyash, V., Lehnardt, S., Kaminska, B., Glass, R., Kettenmann, H., Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 12530–12535.
37. Wu, A., Wei, J., Kong, L.Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., Heimberger, A.B., Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro-Oncology 12 (2010), 1113–1125.
38. Hu, F., Ku, M.C., Markovic, D., Dzaye, O.D. a, Lehnardt, S., Synowitz, M., Wolf, S.A., Kettenmann, H., Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline. Int. J. Cancer 135 (2014), 2569–2578.
39. Hu, F., Dzaye, O.D. a, Hahn, A., Yu, Y., Scavetta, R.J., Dittmar, G., Kaczmarek, A.K., Dunning, K.R., Ricciardelli, C., Rinnenthal, J.L., Heppner, F.L., Lehnardt, S., Synowitz, M., Wolf, S.A., Kettenmann, H., Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages toll-like receptor 2 signaling. Neuro-Oncology 17 (2015), 200–210.
40. Hamilton, L., Astell, K.R., Velikova, G., Sieger, D., A Zebrafish live imaging model reveals differential responses of microglia toward glioblastoma cells in vivo. Zebrafish 13 (2016), 523–534.
41. Hour, M.J., Liu, W.T., Lu, I.C., Kuo, S.C., Gean, P.W., Aggravated DNA damage as a basis for enhanced glioma cell killing by MJ-66 in combination with minocycline. Am. J. Cancer Res. 4 (2014), 474–483.
42. Salacz, M.E., Kast, R.E., Saki, N., Bruning, A., Karpel-Massler, G., Halatsch, M.E., Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen. Onco Targets Ther. 9 (2016), 2535–2545.
43. Feng, X., Szulzewsky, F., Yerevanian, A., Chen, Z., Heinzmann, D., Rasmussen, R.D., Alvarez-Garcia, V., Kim, Y., Wang, B., Tamagno, I., Zhou, H., Li, X., Kettenmann, H., Ransohoff, R.M., Hambardzumyan, D., Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis. Oncotarget 6 (2015), 15077–15094.
44. Xue, N., Zhou, Q., Ji, M., Jin, J., Lai, F., Chen, J., Zhang, M., Jia, J., Yang, H., Zhang, J., Li, W., Jiang, J., Chen, X., Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype. Sci. Rep., 7, 2017, 39011.
45. Li, B., Zhang, C., He, F., Liu, W., Yang, Y., Liu, H., Liu, X., Wang, J., Zhang, L., Deng, B., Gao, F., Cui, J., Liu, C., Cai, J., GSK-3beta inhibition attenuates LPS-induced death but aggravates radiation-induced death via down-regulation of IL-6. Cell. Physiol. Biochem. 32 (2013), 1720–1728.
46. Chikano, Y., Domoto, T., Furuta, T., Sabit, H., Kitano-Tamura, A., Pyko, I.V., Takino, T., Sai, Y., Hayashi, Y., Sato, H., Miyamoto, K., Nakada, M., Minamoto, T., Glycogen synthase kinase 3beta sustains invasion of glioblastoma via the focal adhesion kinase, Rac1, and c-Jun N-terminal kinase-mediated pathway. Mol. Cancer Ther. 14 (2015), 564–574.
47. Acebron, S.P., Niehrs, C., Beta-catenin-independent roles of Wnt/LRP6 signaling. Trends Cell Biol. 26 (2016), 956–967.
48. Amado, N.G., Fonseca, B.F., Cerqueira, D.M., Neto, V.M., Abreu, J.G., Flavonoids: potential Wnt/beta-catenin signaling modulators in cancer. Life Sci. 89 (2011), 545–554.
49. Halleskog, C., Schulte, G., Pertussis toxin-sensitive heterotrimeric G(alphai/o) proteins mediate WNT/beta-catenin and WNT/ERK1/2 signaling in mouse primary microglia stimulated with purified WNT-3A. Cell. Signal. 25 (2013), 822–828.
50. Ajmone-Cat, M.A., D'Urso, M.C., di Blasio, G., Brignone, M.S., De Simone, R., Minghetti, L., Glycogen synthase kinase 3 is part of the molecular machinery regulating the adaptive response to LPS stimulation in microglial cells. Brain Behav. Immun. 55 (2016), 225–235.
51. Zhou, W., Ke, S.Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A.E., McLendon, R.E., Li, X., Rich, J.N., Bao, S., Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat. Cell Biol. 17 (2015), 170–182.
52. Zhang, F., Zhang, Z., Sun, D., Dong, S., Xu, J., Dai, F., Periostin: a downstream mediator of EphB4-induced osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Stem Cells Int., 2016, 2016, 7241829.
53. Inestrosa, N.C., Varela-Nallar, L., Wnt signaling in the nervous system and in Alzheimer's disease. J. Mol. Cell Biol. 6 (2014), 64–74.
54. Silva-Garcia, O., Valdez-Alarcon, J.J., Baizabal-Aguirre, V.M., The Wnt/beta-catenin signaling pathway controls the inflammatory response in infections caused by pathogenic bacteria. Mediat. Inflamm., 2014, 2014, 310183.
55. Liu, X., Wu, S., Xia, Y., Li, X.E., Xia, Y., Zhou, Z.D., Sun, J., Wingless homolog Wnt11 suppresses bacterial invasion and inflammation in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 301 (2011), G992–G1003.
56. Barker, N., Clevers, H., Mining the Wnt pathway for cancer therapeutics. Nat. Rev. Drug Discov. 5 (2006), 997–1014.
57. Gordon, M.D., Nusse, R., Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem. 281 (2006), 22429–22433.
58. Amado, N.G., Cerqueira, D.M., Menezes, F.S., da Silva, J.F., Neto, V.M., Abreu, J.G., Isoquercitrin isolated from Hyptis fasciculata reduces glioblastoma cell proliferation and changes beta-catenin cellular localization. Anti-Cancer Drugs 20 (2009), 543–552.
59. Niehrs, C., The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 13 (2012), 767–779.
60. Acebron, S.P., Karaulanov, E., Berger, B.S., Huang, Y.L., Niehrs, C., Mitotic wnt signaling promotes protein stabilization and regulates cell size. Mol. Cell 54 (2014), 663–674.
61. Taelman, V.F., Dobrowolski, R., Plouhinec, J.L., Fuentealba, L.C., Vorwald, P.P., Gumper, I., Sabatini, D.D., De Robertis, E.M., Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143 (2010), 1136–1148.
62. Kaur, N., Chettiar, S., Rathod, S., Rath, P., Muzumdar, D., Shaikh, M.L., Shiras, A., Wnt3a mediated activation of Wnt/beta-catenin signaling promotes tumor progression in glioblastoma. Mol. Cell. Neurosci. 54 (2013), 44–57.
63. McCrea, P.D., Gottardi, C.J., Beyond beta-catenin: prospects for a larger catenin network in the nucleus. Nat. Rev. Mol. Cell Biol. 17 (2016), 55–64.
64. Lee, Y., Lee, J.K., Ahn, S.H., Lee, J., Nam, D.H., WNT signaling in glioblastoma and therapeutic opportunities. Lab. Invest. 96 (2016), 137–150.
65. Kahlert, U.D., Maciaczyk, D., Doostkam, S., Orr, B.A., Simons, B., Bogiel, T., Reithmeier, T., Prinz, M., Schubert, J., Niedermann, G., Brabletz, T., Eberhart, C.G., Nikkhah, G., Maciaczyk, J., Activation of canonical WNT/beta-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. Cancer Lett. 325 (2012), 42–53.
66. Jin, X., Jeon, H.Y., Joo, K.M., Kim, J.K., Jin, J., Kim, S.H., Kang, B.G., Beck, S., Lee, S.J., Kim, J.K., Park, A.K., Park, W.Y., Choi, Y.J., Nam, D.H., Kim, H., Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res. 71 (2011), 3066–3075.
67. Hirano, H., Yonezawa, H., Yunoue, S., Habu, M., Uchida, H., Yoshioka, T., Kishida, S., Kishida, M., Oyoshi, T., Fujio, S., Sugata, S., Yamahata, H., Hanaya, R., Arita, K., Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostaining. Brain Tumor Pathol. 31 (2014), 85–93.
68. Zhang, Z., Schittenhelm, J., Guo, K., Buhring, H.J., Trautmann, K., Meyermann, R., Schluesener, H.J., Upregulation of frizzled 9 in astrocytomas. Neuropathol. Appl. Neurobiol. 32 (2006), 615–624.
69. Gotze, S., Wolter, M., Reifenberger, G., Muller, O., Sievers, S., Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas. Int. J. Cancer 126 (2010), 2584–2593.
70. Lathia, J.D., Mack, S.C., Mulkearns-Hubert, E.E., Valentim, C.L., Rich, J.N., Cancer stem cells in glioblastoma. Genes Dev. 29 (2015), 1203–1217.
71. Lie, D.C., Colamarino, S.A., Song, H.J., Desire, L., Mira, H., Consiglio, A., Lein, E.S., Jessberger, S., Lansford, H., Dearie, A.R., Gage, F.H., Wnt signalling regulates adult hippocampal neurogenesis. Nature 437 (2005), 1370–1375.
72. Halleskog, C., Dijksterhuis, J.P., Kilander, M.B., Becerril-Ortega, J., Villaescusa, J.C., Lindgren, E., Arenas, E., Schulte, G., Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation. J. Neuroinflammation, 9, 2012, 111.
73. Kahlert, U.D., Suwala, A.K., Koch, K., Natsumeda, M., Orr, B.A., Hayashi, M., Maciaczyk, J., Eberhart, C.G., Pharmacologic Wnt inhibition reduces proliferation, survival, and clonogenicity of glioblastoma cells. J. Neuropathol. Exp. Neurol. 74 (2015), 889–900.
74. Brennan, C., Momota, H., Hambardzumyan, D., Ozawa, T., Tandon, A., Pedraza, A., Holland, E., Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One, 4, 2009, e7752.
75. Gong, A., Huang, S., FoxM1 and Wnt/beta-catenin signaling in glioma stem cells. Cancer Res. 72 (2012), 5658–5662.
76. Kim, S.A., Kwak, J., Nam, H.Y., Chun, S.M., Lee, B.W., Lee, H.J., Khang, S.K., Kim, S.W., Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/beta-catenin pathway in human astrocytoma: pathologic and prognostic correlations. Mod. Pathol. 26 (2013), 626–639.
77. Binda, E., Visioli, A., Giani, F., Trivieri, N., Palumbo, O., Restelli, S., Dezi, F., Mazza, T., Fusilli, C., Legnani, F., Carella, M., Di Meco, F., Duggal, R., Vescovi, A.L., Wnt5a drives an invasive phenotype in human glioblastoma stem-like cells. Cancer Res. 77 (2017), 996–1007.
78. Denysenko, T., Annovazzi, L., Cassoni, P., Melcarne, A., Mellai, M., Schiffer, D., WNT/beta-catenin signaling pathway and downstream modulators in low- and high-grade glioma. Cancer Genomics Proteomics 13 (2016), 31–45.
79. Gattinoni, L., Zhong, X.S., Palmer, D.C., Ji, Y., Hinrichs, C.S., Yu, Z., Wrzesinski, C., Boni, A., Cassard, L., Garvin, L.M., Paulos, C.M., Muranski, P., Restifo, N.P., Wnt signaling arrests effector T cell differentiation and generates CD8 + memory stem cells. Nat. Med. 15 (2009), 808–813.
80. Chen, K., Fu, Q., Li, D., Wu, Y., Sun, S., Zhang, X., Wnt3a suppresses Pseudomonas aeruginosa-induced inflammation and promotes bacterial killing in macrophages. Mol. Med. Rep. 13 (2016), 2439–2446.
81. Suryawanshi, A., Manoharan, I., Hong, Y., Swafford, D., Majumdar, T., Taketo, M.M., Manicassamy, B., Koni, P.A., Thangaraju, M., Sun, Z., Mellor, A.L., Munn, D.H., Manicassamy, S., Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation. J. Immunol. 194 (2015), 3295–3304.
82. Nayak, L., Lee, E.Q., Wen, P.Y., Epidemiology of brain metastases. Curr. Oncol. Rep. 14 (2012), 48–54.
83. Yao, Y.L., Ma, J., Wang, P., Xue, Y.X., Li, Z., Zhao, L.N., Li, Z.Q., Feng, T.D., Liu, Y.H., miR-101 acts as a tumor suppressor by targeting Kruppel-like factor 6 in glioblastoma stem cells. CNS Neurosci. Ther. 21 (2015), 40–51.
84. Smits, M., Nilsson, J., Mir, S.E., van der Stoop, P.M., Hulleman, E., Niers, J.M., de Witt Hamer, P.C., Marquez, V.E., Cloos, J., Krichevsky, A.M., Noske, D.P., Tannous, B.A., Wurdinger, T., miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget 1 (2010), 710–720.
85. Codocedo, J.F., Inestrosa, N.C., Wnt-5a-regulated miR-101b controls COX2 expression in hippocampal neurons. Biol. Res., 49, 2016, 9.
86. Nunez, F., Bravo, S., Cruzat, F., Montecino, M., De Ferrari, G.V., Wnt/beta-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells. PLoS One, 6, 2011, e18562.
87. Haertel-Wiesmann, M., Liang, Y., Fantl, W.J., Williams, L.T., Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J. Biol. Chem. 275 (2000), 32046–32051.
88. Jang, J., Jung, Y., Kim, Y., Jho, E.H., Yoon, Y., LPS-induced inflammatory response is suppressed by Wnt inhibitors, Dickkopf-1 and LGK974. Sci. Rep., 7, 2017, 41612.
89. Dijksterhuis, J.P., Arthofer, E., Marinescu, V.D., Nelander, S., Uhlen, M., Ponten, F., Mulder, J., Schulte, G., High levels of WNT-5A in human glioma correlate with increased presence of tumor-associated microglia/monocytes. Exp. Cell Res. 339 (2015), 280–288.